Patents by Inventor Natalie McDonald

Natalie McDonald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mammalian Genes Involved in Infection
    Publication number: 20130323835
    Abstract: The present invention relates to nucleic acid sequences and cellular proteins encoded by these sequences that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.
    Type: Application
    Filed: July 15, 2010
    Publication date: December 5, 2013
    Applicant: Zirus, Inc.
    Inventors: Natalie Mcdonald, Donald Rubin, Thomas Hodge, James Murray
  • Mammalian Genes Involved in Tularemia and Other Infections
    Publication number: 20130067609
    Abstract: The present invention relates to nucleic acid sequences and cellular proteins encoded by these sequences that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.
    Type: Application
    Filed: June 14, 2010
    Publication date: March 14, 2013
    Inventors: Donald Rubin, Robert Gilmore, Thomas Hodge, Natalie McDonald
  • Rab9a, rab11a, and modulators thereof related to infectious disease
    Publication number: 20070087008
    Abstract: Disclosed herein are methods of reducing infection of a cell by a pathogen, for example to treat or prevent a pathogen infection. Exemplary pathogens include those that use a lipid raft. The disclosure also relates to methods of identifying agents involved in pathogen infection, such as modulators of Rab9A and Rab11A.
    Type: Application
    Filed: February 24, 2005
    Publication date: April 19, 2007
    Inventors: Thomas Hodge, Natalie McDonald, Donald Rubin, Michaewl Shaw, Anthony Sanchez, James Murray
  • Cell lines and host nucleic acid sequences related to infectious disease
    Publication number: 20060257872
    Abstract: Host nucleic acids and host proteins that participate in viral infection, such as human immunodeficiency virus (HIV), influenza A, and Ebola virus, have been identified. Interfering with or disrupting the interaction between a host nucleic acid or host protein and a virus or viral protein confers an inhibition of or resistance to infection. Thus, interfering with such an interaction in a host subject can confer a therapeutic or prophylactic effect against a virus. The sequences identified can be used to identify agents that reduce or inhibit viral infection.
    Type: Application
    Filed: November 18, 2003
    Publication date: November 16, 2006
    Inventors: Thomas Hodge, Natalie McDonald, Michael Shaw, Donald Rubin, Anthony Sanchez